Item Type | Name |
Concept
|
Psychiatry
|
Concept
|
Diagnosis, Dual (Psychiatry)
|
Academic Article
|
Genitourinary and sexual adverse effects of psychotropic medication.
|
Academic Article
|
Personality disorders in patients with panic disorder: association with childhood anxiety disorders, early trauma, comorbidity, and chronicity.
|
Academic Article
|
Long-term management of panic disorder.
|
Academic Article
|
Fluoxetine treatment of cocaine abuse in heroin addicts.
|
Academic Article
|
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
|
Academic Article
|
Pilot outreach services to homebound agoraphobic patients.
|
Academic Article
|
Clonazepam for the treatment of social phobia.
|
Academic Article
|
Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study.
|
Academic Article
|
Fluoxetine-induced sexual dysfunction.
|
Academic Article
|
Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder.
|
Academic Article
|
Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report.
|
Academic Article
|
Cocaine abuse and treatment.
|
Academic Article
|
Acute distress after switch from Norpramin to generic desipramine.
|
Academic Article
|
Enhancement of ECT benefit by yohimbine.
|
Academic Article
|
Clonazepam: a review of open clinical trials.
|
Academic Article
|
Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
|
Academic Article
|
Calcium channel blockers in psychiatry.
|
Academic Article
|
Anhedonic ejaculation with desipramine.
|
Academic Article
|
Verapamil in the treatment of recurrent unipolar depression.
|
Academic Article
|
Oculocutaneous albinism and schizophrenia.
|
Academic Article
|
On panic attacks and neurologic problems.
|
Academic Article
|
Management of antidepressant-induced side effects: a practical guide for the clinician.
|
Academic Article
|
Treatment-emergent incontinence with lithium.
|
Academic Article
|
Birth weight and length in schizophrenics personality disorders and their siblings.
|
Academic Article
|
Siblings of schizophrenic and nonschizophrenic psychiatric patients. Psychopathology and gender concordance.
|
Academic Article
|
Follow-up study of formerly hospitalized voluntary psychiatric patients: the first two years.
|
Academic Article
|
EEG abnormalities in patients with atypical panic attacks.
|
Academic Article
|
Innovative uses of benzodiazepines in psychiatry.
|
Academic Article
|
Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report.
|
Academic Article
|
Cognitive behavior therapy for treatment-refractory panic disorder.
|
Academic Article
|
Sleep panic attacks: an association with childhood anxiety and adult psychopathology.
|
Academic Article
|
Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder.
|
Academic Article
|
Adjunctive yohimbine for treatment in refractory depression.
|
Academic Article
|
Prevalence of panic in patients referred for pulmonary function testing at a major medical center.
|
Academic Article
|
Relationship of childhood anxiety to adult panic disorder: correlates and influence on course.
|
Academic Article
|
Treatment of dysphoric mania with nefazodone.
|
Academic Article
|
Should the administration of ECT during clozapine therapy be contraindicated?
|
Academic Article
|
Clinical issues in the long-term treatment of panic disorder.
|
Academic Article
|
Long-term course and outcome of panic disorder.
|
Academic Article
|
Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
|
Academic Article
|
Childhood history of anxiety in adults with panic disorder: association with anxiety sensitivity and comorbidity.
|
Academic Article
|
Treatment strategies for panic disorder: a debate.
|
Academic Article
|
The hidden costs of untreated anxiety disorders.
|
Academic Article
|
Social phobia: an update.
|
Academic Article
|
Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction.
|
Academic Article
|
Gabapentin as a potential treatment for anxiety disorders.
|
Academic Article
|
Dizziness and panic disorder: a review of the association between vestibular dysfunction and anxiety.
|
Academic Article
|
How do clinicians respond to patients who miss appointments?
|
Academic Article
|
Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.
|
Academic Article
|
Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.
|
Academic Article
|
Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.
|
Academic Article
|
Social anxiety disorder: designing a pharmacologic treatment strategy.
|
Academic Article
|
Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group.
|
Academic Article
|
Cerebral phosphorus metabolite abnormalities in opiate-dependent polydrug abusers in methadone maintenance.
|
Academic Article
|
Clinician response to treatment refractory panic disorder: a survey of psychiatrists.
|
Academic Article
|
Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.
|
Academic Article
|
Is placebo response the same as drug response in panic disorder?
|
Academic Article
|
New developments in panic disorder.
|
Academic Article
|
Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
|
Academic Article
|
Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
|
Academic Article
|
Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder.
|
Academic Article
|
Citalopram for social phobia: a clinical case series.
|
Academic Article
|
Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission.
|
Academic Article
|
An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder.
|
Academic Article
|
Strategies for treatment of SSRI-associated sexual dysfunction: a survey of an academic psychopharmacology practice.
|
Academic Article
|
Somatic panic-attack equivalents in a community sample of Rwandan widows who survived the 1994 genocide.
|
Academic Article
|
Relationship between adult social phobia and childhood anxiety.
|
Academic Article
|
Inhalant-induced convulsions. Significance for the theory of the convulsive therapy process.
|
Academic Article
|
PERCEPTUAL EVIDENCE OF CNS DYSFUNCTION IN SCHIZOPHRENIA.
|
Academic Article
|
Establishment of remission criteria for anxiety disorders.
|
Academic Article
|
Long-term management of panic disorder.
|
Academic Article
|
Moderating effects of major depression on patterns of comorbidity in patients with panic disorder.
|
Academic Article
|
White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects.
|
Academic Article
|
An open-label study of levetiracetam for the treatment of social anxiety disorder.
|
Academic Article
|
Olfactory-triggered panic attacks among Khmer refugees: a contextual approach.
|
Academic Article
|
Cerebral phosphorus metabolite and transverse relaxation time abnormalities in heroin-dependent subjects at onset of methadone maintenance treatment.
|
Academic Article
|
Olfactory-triggered panic attacks among Cambodian refugees attending a psychiatric clinic.
|
Academic Article
|
Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
|
Academic Article
|
Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents.
|
Academic Article
|
Discussion: using benzodiazepines in clinical practice.
|
Academic Article
|
The pharmacotherapy of panic disorder.
|
Academic Article
|
'The ghost pushes you down': sleep paralysis-type panic attacks in a Khmer refugee population.
|
Academic Article
|
Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
|
Academic Article
|
Does recovery from substance use disorder matter in patients with bipolar disorder?
|
Academic Article
|
Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study.
|
Academic Article
|
Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
|
Academic Article
|
Complicated grief and its correlates in patients with bipolar disorder.
|
Academic Article
|
Comorbid anxiety and depression.
|
Academic Article
|
The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study.
|
Academic Article
|
Using neuroimaging to predict treatment response in mood and anxiety disorders.
|
Academic Article
|
Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
|
Academic Article
|
Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging.
|
Academic Article
|
An open-label trial of risperidone augmentation for refractory anxiety disorders.
|
Academic Article
|
Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder.
|
Academic Article
|
Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders.
|
Academic Article
|
Preventing recurrent depression: long-term treatment for major depressive disorder.
|
Academic Article
|
Levetiracetam as adjunctive therapy for refractory anxiety disorders.
|
Academic Article
|
Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study.
|
Academic Article
|
Complicated grief: a case series using escitalopram.
|
Academic Article
|
Complicated grief and impaired sleep in patients with bipolar disorder.
|
Academic Article
|
Orthostatic panic attacks among Vietnamese refugees.
|
Academic Article
|
High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam.
|
Academic Article
|
Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy.
|
Academic Article
|
Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
|
Academic Article
|
The 'multiplex model' of somatic symptoms: application to tinnitus among traumatized Cambodian refugees.
|
Academic Article
|
Brain GABA levels in patients with bipolar disorder.
|
Academic Article
|
Nightmares among Cambodian refugees: the breaching of concentric ontological security.
|
Academic Article
|
Refractory generalized anxiety disorder.
|
Academic Article
|
Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.
|
Academic Article
|
Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
|
Academic Article
|
Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial.
|
Academic Article
|
Khyâl attacks: a key idiom of distress among traumatized cambodia refugees.
|
Academic Article
|
Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.
|
Academic Article
|
Predicting treatment response in social anxiety disorder from functional magnetic resonance imaging.
|
Academic Article
|
D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia.
|
Academic Article
|
Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity.
|
Academic Article
|
D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.
|
Academic Article
|
A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder.
|
Academic Article
|
The human ortholog of acid-sensing ion channel gene ASIC1a is associated with panic disorder and amygdala structure and function.
|
Academic Article
|
Response to Silberman.
|
Academic Article
|
D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update.
|
Academic Article
|
Brain connectomics predict response to treatment in social anxiety disorder.
|
Academic Article
|
Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.
|
Academic Article
|
Panic Disorder and Chest Pain: Mechanisms, Morbidity, and Management.
|
Academic Article
|
D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
|
Academic Article
|
The effect of mindfulness meditation training on biological acute stress responses in generalized anxiety disorder.
|
Academic Article
|
Examining the Relationship Between Parent and Child Psychopathology in Treatment-Seeking Veterans.
|
Academic Article
|
Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSD.
|
Academic Article
|
Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia.
|